The Supply Chain Redefined: Cell and Gene Therapies

By AmerisourceBergen |
Insights Home

Learn More

Read our ebook to find out more about commercializing cell and gene therapies. 

Download the ebook
Topics:
Cell and Gene Therapy Third Party Logistics Commercialization Commercial Supply Chain

Related Content

Manufacturers

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

Pete Belden
ICS
July 2017

In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.

Manufacturers

Commercializing Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2017

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.

Health Systems

Our Most-Read Insights of 2018

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2018

A collection of AmerisourceBergen's top insights from 2018, including commercialization considerations for novel therapies, emerging trends in retail and specialty pharmacy and best practices for managing inventory in the specialty practice.